Contact Us
Patients Health Care Professionals Corporate Tissue Services Career Opportunities
Search
Parotidectomy
Injection Laryngoplasty
Mastoidectomy
Tympanoplasty
Septal perforation
ENT/head and neck reconstruction abstracts

ENT/Head and Neck Reconstruction Abstracts

Acellular dermis for facial soft tissue augmentation: preliminary report.


Costantino PD, Govindaraj S, Hiltzik DH, Buchbinder D, Urken ML.

Arch Facial Plast Surg. 2001 Jan-Mar;3(1):38-43.

Department of Otolaryngology, Box 1189, The Mount Sinai Medical Center, 1 Gustave L. Levy Pl, New York, NY 10029, USA.

OBJECTIVE: To evaluate the efficacy of acellular dermis as a viable alternative for soft tissue augmentation in facial reconstruction. DESIGN: A prospective, nonrandomized observational study consisting of 10 patients who underwent soft tissue augmentation with acellular dermis. SETTING: A tertiary care university medical center in an urban setting. PATIENTS: Ten patients who had undergone soft tissue augmentation using acellular dermis participated in this study. Postimplantation follow-up was 17 to 36 months. INTERVENTION: The amount and location for placement of the acellular dermis was left to the discretion of the surgeon. All implants were placed in the subdermal tissues. MAIN OUTCOME MEASURES: The adequacy of acellular dermis for soft tissue augmentation was assessed by subjective evaluation of implant volume persistence, postoperative complications, and the restoration of normal contour. RESULTS: Of 10 patients who underwent implantation, 9 had no complications and 1 had a recurrent sterile abscess or mucocele at the implantation site. A 22-month postimplantation tissue sampling of acellular dermis in a patient with recurrent tumor revealed approximately 80% to 85% volume persistence. CONCLUSION: Preliminary experience with acellular dermis indicates that it shows promise in soft tissue augmentation.